Breaking News

Emergent BioSolutions Launches Singapore Operations

Emergent BioSolutions, Inc. has launched Singapore operations through EPIC Bio Ltd., a joint venture with Temasek Life Sciences Ventures Ltd. (TLV), to develop, manufacture, and commercialize pandemic influenza vaccines and therapeutics.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Emergent BioSolutions, Inc., a U.S.-based developer and manufacturer of vaccines and antibody therapies, has launched Singapore operations through EPIC Bio Ltd., a recently formed Singapore-based joint venture with Temasek Life Sciences Ventures Ltd. (TLV), to develop, manufacture, and commercialize pandemic influenza vaccines and therapeutics. Emergent’s Singapore office will provide support to EPIC Bio as the joint venture expands its operations. EPIC Bio plans to begin clinical manufacturi...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters